CH603164A5 - - Google Patents

Info

Publication number
CH603164A5
CH603164A5 CH15775A CH15775A CH603164A5 CH 603164 A5 CH603164 A5 CH 603164A5 CH 15775 A CH15775 A CH 15775A CH 15775 A CH15775 A CH 15775A CH 603164 A5 CH603164 A5 CH 603164A5
Authority
CH
Switzerland
Application number
CH15775A
Inventor
Robert Fauve
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of CH603164A5 publication Critical patent/CH603164A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH15775A 1974-01-10 1975-01-08 CH603164A5 (lm)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7400842A FR2257266B1 (lm) 1974-01-10 1974-01-10

Publications (1)

Publication Number Publication Date
CH603164A5 true CH603164A5 (lm) 1978-08-15

Family

ID=9133334

Family Applications (1)

Application Number Title Priority Date Filing Date
CH15775A CH603164A5 (lm) 1974-01-10 1975-01-08

Country Status (4)

Country Link
US (1) US4310513A (lm)
CH (1) CH603164A5 (lm)
DE (1) DE2500771A1 (lm)
FR (1) FR2257266B1 (lm)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703002A (en) * 1985-05-01 1987-10-27 Eastman Kodak Company Method for preparing coating compositions containing an immunologically reactive species and elements containing same
US4847078A (en) * 1987-01-14 1989-07-11 Arseco, Inc. Storage stable topical composition having moisture control agent
NL194638C (nl) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat.
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2897120A (en) * 1954-05-04 1959-07-28 Upjohn Co Low viscosity cmc pharmaceutical vehicle
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
US2908614A (en) * 1954-08-10 1959-10-13 Glaxo Lab Ltd Use of dextran in freeze-drying process
US3062712A (en) * 1959-11-09 1962-11-06 Upjohn Co Prednisolone sesquihydrate compositions
US3541201A (en) * 1968-12-18 1970-11-17 Ethan Alan Brown Novel sodium chloride encapsulated injectionable substances
US4180563A (en) * 1971-12-24 1979-12-25 Institut Pasteur Immunostimulant agent from Salmonella typhimurium or Listeria monocytogenes bacterial cells and pharmaceutical composition
US4076801A (en) * 1972-12-20 1978-02-28 Institut Pasteur Immunostimulant agent, compositions thereof and methods for their preparation

Also Published As

Publication number Publication date
FR2257266A1 (lm) 1975-08-08
FR2257266B1 (lm) 1977-07-01
DE2500771A1 (de) 1975-07-17
US4310513A (en) 1982-01-12

Similar Documents

Publication Publication Date Title
JPS50133030A (lm)
FR2256435B1 (lm)
FR2257266A1 (lm)
JPS50132351A (lm)
FR2289834B3 (lm)
JPS50108094A (lm)
FR2288454B1 (lm)
FR2296905B1 (lm)
JPS50114659A (lm)
FR2275642B1 (lm)
JPS50103741U (lm)
JPS50100815U (lm)
JPS50115255U (lm)
JPS50102147A (lm)
CS164750B1 (lm)
DE2402627A1 (lm)
JPS50110201U (lm)
FR2257511A2 (lm)
JPS50117930U (lm)
CH580864A5 (lm)
BG19682A1 (lm)
CH581409A5 (lm)
CH581254A5 (lm)
CH581077A5 (lm)
CH572727A5 (lm)

Legal Events

Date Code Title Description
PL Patent ceased